IXHL
Incannex Healthcare, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$3.64
+1.39%Margins
Gross margin
-186.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-62.3%
Return on equity
-58.4%
Return on assets
-31.6%
Return on invested capital
0.00x
Asset turnover
-$12.5M
Cash from operations
$6.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026